net investments of the Boiron Group amounted to 15.2 million euros.
This statistic illustrates the earnings before interest, taxes, depreciation, and amortization (EBITDA) of the Boiron laboratories from 2012 to 2022, in thousands of euros. In 2022, the EBITDA of the group amounted to around 64 million euros and the value of Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Boiron
Overview
5
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Average full-time equivalent workforce of Boiron Laboratories 2012-2022
Turnover
5
- Premium Statistic Boiron laboratories turnover in France 2022, by region
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Global turnover of Boiron's specialties segment 2022, by region
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
Financial data
7
- Premium Statistic Net investments of Boiron laboratories 2014-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Value of assets of Boiron laboratories in 2022, by type
- Premium Statistic Value of the liabilities of Boiron laboratories, by type in 2022
- Premium Statistic Share capital of Boiron laboratories 2012-2022
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
- Premium Statistic Income after tax, profit-sharing, amortizations and reserves of Boiron 2022
Workforce
6
- Premium Statistic Personnel costs of Boiron laboratories 2012-2022
- Premium Statistic Worldwide workforce of Boiron laboratories 2022, by gender
- Premium Statistic Workforce of Boiron laboratories in the World in 2022, by region
- Premium Statistic Distribution of the Boiron laboratories workforce in 2022, by world region
- Premium Statistic Workforce of Boiron laboratories in 2022, by sector of activity
- Premium Statistic Distribution of the workforce of Boiron laboratories in 2022, by activity sector
Shares
5
- Premium Statistic Boiron laboratories' market capitalization at the end of the year 2012-2022
- Premium Statistic Boiron's capital breakdown at the end of 2022, by shareholder
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
- Premium Statistic Dividend of Boiron laboratories 2013-2022, per share
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
Further related statistics
16
- After-tax turnover of Boiron laboratories 2012-2019
- OTC revenue of homeopathic remedies in the U.S. 2011-2017
- Sales of homeopathics and herbal remedies in Germany from 2018 to 2022
- OTC sales volume of homeopathic remedies in the U.S. 2011-2017
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Revenues from herbal and homeopathic medicine in German pharmacies 2020-2022
- Properties of homeopathy according to the French 2018
- Number of alternative medicine and homeopathy employees in Germany 2012-2022
- Italy: traditional medicine vs homeopathic medicine 2016
- Brazil: number of homeopaths 2013-2018
- Canadians' views on removal of labels on homeopathic remedies by ethnicity 2016
- Pharmacy revenue from OTC medicine in Germany 2022
- Over the counter homeopathic and herbal medicine revenue in Germany 2022
- Testosterone use in the U.S. per 1,000 population 2011
- U.S. public approval of medical marijuana 1995-2015
- Revenue per capita of skin treatment in Singapore 2018-2029
Further Content: You might find this interesting as well
Statistics
- After-tax turnover of Boiron laboratories 2012-2019
- OTC revenue of homeopathic remedies in the U.S. 2011-2017
- Sales of homeopathics and herbal remedies in Germany from 2018 to 2022
- OTC sales volume of homeopathic remedies in the U.S. 2011-2017
- Sales volume of over the counter phytopharmaceuticals and homeopathy in Germany 2018
- Revenues from herbal and homeopathic medicine in German pharmacies 2020-2022
- Properties of homeopathy according to the French 2018
- Number of alternative medicine and homeopathy employees in Germany 2012-2022
- Italy: traditional medicine vs homeopathic medicine 2016
- Brazil: number of homeopaths 2013-2018
- Canadians' views on removal of labels on homeopathic remedies by ethnicity 2016
- Pharmacy revenue from OTC medicine in Germany 2022
- Over the counter homeopathic and herbal medicine revenue in Germany 2022
- Testosterone use in the U.S. per 1,000 population 2011
- U.S. public approval of medical marijuana 1995-2015
- Revenue per capita of skin treatment in Singapore 2018-2029
Boiron. (April 14, 2023). Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros) [Graph]. In Statista. Retrieved May 19, 2024, from https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. "Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros)." Chart. April 14, 2023. Statista. Accessed May 19, 2024. https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. (2023). Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros). Statista. Statista Inc.. Accessed: May 19, 2024. https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron. "Earnings before Interest, Taxes, Depreciation, and Amortization (Ebitda) of Boiron Laboratories from 2012 to 2022 (in 1,000s of Euros)." Statista, Statista Inc., 14 Apr 2023, https://www.statista.com/statistics/1073057/boiron-ebitda/
Boiron, Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros) Statista, https://www.statista.com/statistics/1073057/boiron-ebitda/ (last visited May 19, 2024)
Earnings before interest, taxes, depreciation, and amortization (EBITDA) of Boiron laboratories from 2012 to 2022 (in 1,000s of euros) [Graph], Boiron, April 14, 2023. [Online]. Available: https://www.statista.com/statistics/1073057/boiron-ebitda/